without the profit incentive, you will not get the innovation.
somebody is paying. Yes, insurance is making it more affordable. Medicaid is making it more affordable. Medicare is maki...
clearly, patents are part of the free market system, is the way that you protect intellectual property, and you incent c...
Now, value-based purchasing could obviously play a role here.
If you have got an initial high price, no matter what your value-based purchasing arrangement is, it could still be some...
We demand CEOs come before the Committee for public verbal stoning.
I think I recall a couple of years ago there was a study that was shown, respected, and you probably know it better than...
For the sake of those who are watching, a rebate wall is an anti-competitive tool which can be used to restrict a compet...
It is kind of following a formula. Republicans--we publicly attack private--I don't but others, publicly attack private ...
Now, we have been discussing the promise of biosimilars to lower the cost in a market oriented, competitive way.
Now, the affordability though, we are defining affordability for the patient. So, if Medicaid covers it, it is by defini...
I have been concerned that we don't really know how we are going to price those.
whenever you decrease profits, you get less innovation.
Let's make a difference for the people whom we represent--for those patients in hospitals who I once treated who otherwi...
Let's just be clear, everybody on this panel cares about the high cost of prescription drugs and wants to work on real s...
The people of Kansas sent me here to save Medicare.
Very concisely, how are we going to show restraint on the price of some of these new gene therapies?
We support legislation in order to be able to do value based contracts in the case of gene therapy.
